Medtronic Receives CE Mark Approval for Viva CRT-P

by Kathy Jones on  May 8, 2014 at 8:19 PM Medical Gadgets
RSS Email Print This Page Comment
Font : A-A+

Minneapolis-based medical device company Medtronic revealed that it has received the CE Mark of approval from European authorities to market its cardiac resynchronization therapy-pacemaker, Viva CRT-P.
 Medtronic Receives CE Mark Approval for Viva CRT-P
Medtronic Receives CE Mark Approval for Viva CRT-P

The device comes with Medtronic's AdaptivCRT algorithms which can improve the patients' response to the therapy and reduce the risk of atrial fibrillation by preserving normal heart rhythms and automatically adjusting to the patient's needs every minute.

The company added that other tools such as OptiVol Fluid Status Monitoring and Cardiac Compass Report also feature in the device, providing an accurate assessment of rehospitalization risk within 30 days of discharge. While Viva CRT-P has been approved it Europe, it is yet to gain approval from the US Food and Drug Administration.

"The diagnostic capabilities of this smart device help improve function throughout the continuum of care. This represents a win for both patients and physicians and, when coupled with additional longevity, provides another layer of distinct value over a longer period", Medtronic's David Steinhaus said.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive